Immutep
IMMP
#7617
Rank
โ‚น34.75 B
Marketcap
โ‚น236.11
Share price
4.80%
Change (1 day)
31.22%
Change (1 year)

Revenue for Immutep (IMMP)

Revenue in 2024: N/A

According to Immutep's latest financial reports the company's current revenue (TTM ) is -โ‚น0.03 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Immutep from 2008 to 2024

Annual revenue

Year Revenue Change
2024N/A
2023N/A-100%
2022โ‚น10.58 M
2021N/A-100%
2020โ‚น0.46 B5163.29%
2019โ‚น8.84 M-94.96%
2018โ‚น0.17 B
2017N/A-100%
2016โ‚น11.75 M
2015N/A
2014N/A
2013N/A
2012N/A
2011N/A-100%
2010โ‚น3.71 M75.14%
2009โ‚น2.12 M
2008N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Illumina
ILMN
โ‚น386.42 B-1,548,014,540.43%๐Ÿ‡บ๐Ÿ‡ธ USA
HTG Molecular Diagnostics
HTGM
โ‚น0.56 B-2,243,520.94%๐Ÿ‡บ๐Ÿ‡ธ USA
FibroGen
FGEN
-โ‚น10.65 Billion 42,632,751.99%๐Ÿ‡บ๐Ÿ‡ธ USA